Revenue | ₹55.58Cr |
Net Profits | ₹8.19Cr |
Net Profit Margins | 14.74% |
Kilitch Drugs (India) Ltd’s revenue jumped 5.59% since last year same period to ₹55.58Cr in the Q2 2025-2026. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated 21.62% jump in its revenue since last 3-months.
Kilitch Drugs (India) Ltd’s net profit fell -4.99% since last year same period to ₹8.19Cr in the Q2 2025-2026. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated 170.3% jump in its net profits since last 3-months.
Kilitch Drugs (India) Ltd’s net profit margin fell -10.01% since last year same period to 14.74% in the Q2 2025-2026. On a quarterly growth basis, Kilitch Drugs (India) Ltd has generated 122.25% jumped in its net profit margins since last 3-months.
The revenue for Kilitch Drugs (India) Ltd in the Q2 results 2025 was ₹55.58Cr.
The net profit for Kilitch Drugs (India) Ltd in the Q2 results 2025 was ₹8.19Cr.
The net profit margin for Kilitch Drugs (India) Ltd in the Q2 results 2025 was 14.74%.
The revenue for Kilitch Drugs (India) Ltd in the Q2 results 2024 was ₹52.64Cr.
The net profit for Kilitch Drugs (India) Ltd in the Q2 results 2024 was ₹8.62Cr.
The net profit margin for Kilitch Drugs (India) Ltd in the Q2 results 2024 was 16.38%.